Stay updated on AAV2/6 Gene Therapy SB-525 in Severe Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the AAV2/6 Gene Therapy SB-525 in Severe Hemophilia A Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FTiux-ksRubZ075GWKfStvH_UOCo.uncropped.jpg&w=3840&q=75)
Latest updates to the AAV2/6 Gene Therapy SB-525 in Severe Hemophilia A Clinical Trial page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check3 days agoChange DetectedThe study has expanded to include 22 locations, and the website has been updated to version v2.10.0, replacing the previous version v2.9.7.SummaryDifference0.5%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check16 days agoChange DetectedThe website now displays the actual last update posted instead of an estimated time, providing users with more accurate information.SummaryDifference0.1%
- Check17 days agoChange DetectedThe website has added new locations in Nashville, Tennessee, including the Vanderbilt University Medical Center Clinical Research Center and the Vanderbilt Hemostasis Treatment Clinic, with the last update posted on July 8th.SummaryDifference3%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.SummaryDifference0.1%
- Check30 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content related to the study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 in Subjects With Severe Hemophilia A, specifically focusing on the safety, tolerability, and time-course profile of FVIII activity after dosing with SB-525 (PF-07055480).SummaryDifference0.1%
Stay in the know with updates to AAV2/6 Gene Therapy SB-525 in Severe Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AAV2/6 Gene Therapy SB-525 in Severe Hemophilia A Clinical Trial page.